Beta Bionics, Inc. (BBNX) Capital Expenditures (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Capital Expenditures data on file, last reported at $1.4 million in Q1 2026.

• Quarterly Capital Expenditures rose 313.51% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (up 90.88% YoY) and the FY2025 annual result came in at $5.3 million, up 56.02% from the prior year.
• Capital Expenditures fell to $1.4 million in Q1 2026 per BBNX's latest filing, from $5.3 million in the prior quarter.
• The five-year high for Capital Expenditures was $5.3 million in Q4 2025, with the low at -$232000.0 in Q2 2025.
• Average Capital Expenditures over 3 years is $1.1 million, with a median of $550000.0 recorded in 2024.
• The widest YoY moves for Capital Expenditures: up 837.43% in 2025, down 142.18% in 2025.
• Beta Bionics' Capital Expenditures stood at $561000.0 in 2024, then surged by 837.43% to $5.3 million in 2025, then tumbled by 73.82% to $1.4 million in 2026.
• Business Quant data shows BBNX's Capital Expenditures at $1.4 million in Q1 2026, $5.3 million in Q4 2025, and -$63000.0 in Q3 2025.